BIVDA Press Releases

02Dec

Press Release - BIVDA welcomes approval of new COVID-19 vaccine

 

BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators.

 

Doris-Ann said;

 

“We are delighted that the MHRA have approved the Pfizer/BioNTech coronavirus vaccine for widespread use, meaning it can start its roll out from next week. On behalf of BIVDA and the in vitro diagnostics sector, I would like to congratulate all those involved in this incredible scientific achievement.

 

An effective vaccine, combined with an effective test and trace system, is our best route back to normality, and indeed both prongs of this approach are interdependent. We will continue to work closely with the MHRA, NHS and Ministers to play our role in supporting the continued implementation of effective and rapid COVID-19 testing, so cases can be detected and controlled while the vaccine is being distributed.

 

Once the virus is on the retreat, the Government must continue to support the NHS to restart and scale up routine testing to avoid a tsunami of undiagnosed illnesses presenting themselves next year, just when pressure on the NHS from COVID-19 may begin to ease. Our members stand ready to play their part in the next stage of this important endeavour.”

 

ENDS

 

 

For more information please contact BIVDA External Affairs Manager Jon Harrison jonh@bivda.org.uk

Related

Press Release - BIVDA IVD Market Audit Results Show COVID-19 Impact

BIVDA Press Release – For Immediate Release  ---  BIVDA IVD Market Audit Result...

Read More >

Press Release - BIVDA Comments on COVID-19 antibody test authorisation by Public Health England

Dear All Please see below and attached a press release from BIVDA with a comment from our Chief...

Read More >

UK Continues to Lag EU Market for In-Vitro Diagnostic Expenditure

The European IVD Market Statistics Report 2016 has been published by MedTech Europe and is available...

Read More >

Press Release - BIVDA Response to COVID-19 Border Closures

A short statement has been released by BIVDA’s Chief Operating Officer Helen Dent on the COVID...

Read More >

BIVDA comment on the Health and Social Care Committee’s report into Antimicrobial resistance

Today the Health and Social Care Committee has published its report on Antimicrobial resistance.

Read More >

BIVDA Press Release - UK Rare Diseases Framework

BIVDA Statement on UK Rare Disease Framework BIVDA Chief Executive Doris-Ann Williams has welco...

Read More >